December 21, 2024 - 12:01

Meet Seema Donahoe, a prominent figure at the School of Public Health at the University of Nevada, Reno. With a passion for improving community health and wellness, Donahoe has dedicated her career to advancing public health initiatives and education. Her expertise encompasses a wide range of topics, including health policy, epidemiology, and health promotion.
In her role at the university, Donahoe is committed to shaping the next generation of public health professionals. She engages students through innovative teaching methods and hands-on learning experiences, ensuring they are well-prepared to tackle the pressing health challenges of today. Her research focuses on critical issues affecting populations, aiming to develop strategies that lead to healthier communities.
Donahoe's contributions extend beyond the classroom, as she actively collaborates with local health organizations to implement programs that address health disparities. Her work exemplifies the vital role of public health educators in fostering healthier environments and improving quality of life for all.
July 21, 2026 - 17:42
Rare disease drugmakers try to avoid Trump price cutsPharmaceutical companies that specialize in treatments for rare diseases are scrambling to shield their products from possible price cuts under a potential second Trump administration. During his...
July 21, 2026 - 06:41
The rise of Zyn-like pouches for sleep, health, focus, teethThe success of Zyn nicotine pouches has sparked a wave of copycat products that promise to deliver everything from better sleep to sharper focus, all through a small pouch tucked inside the lip....
July 20, 2026 - 19:14
FDA says it’s still investigating Taylor Farms in cyclosporiasis outbreakThe U.S. Food and Drug Administration has clarified that a false-positive lab result does not alter the `overwhelming epidemiological data` pointing to Taylor Farms as the source of a...
July 20, 2026 - 11:31
Seven peptides are under review by an FDA panel this week. Here’s everything we knowA federal advisory committee is set to meet this week to evaluate seven peptide products, a move that could reshape how these compounds are made and prescribed in the United States. The panel,...